AIxCrypto Holdings, Inc. (AIXC)
Nasdaq: AIXC · Finance Services · California, CA · filing with the SEC since 2009
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 202612 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to AIxCrypto Holdings, Inc.’s names, not what it holds today.
Patents granted
12
12 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
24
since 2001, to Dec 31, 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Ritter Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
13 published
Ritter Pharmaceuticals, Inc. a former name
named as the applicant on its applications, in US
11 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jun 8, 2021 | 11,028,422 | Process for the production of ultrapure galacto-oligosaccharides | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Nov 7, 2017 | 9,808,481 | Prebiotic formulations and methods of use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Oct 3, 2017 | 9,775,860 | Prebiotic formulations and methods of use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Mar 14, 2017 | 9,592,248 | Prebiotic formulations and methods of use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Feb 28, 2017 | 9,579,340 | Prebiotic formulations and methods of use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Jun 21, 2016 | 9,370,532 | Prebiotic formulations and methods of use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Jan 5, 2016 | 9,226,933 | Methods and compositions for treating lactose intolerance | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Dec 1, 2015 | 9,200,303 | Process for the production of ultrapure galacto-oligosaccharides | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Jul 22, 2014 | 8,785,160 | Prebiotic formulations and methods of use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Jul 23, 2013 | 8,492,124 | Prebiotic formulations and methods of use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| May 9, 2019 | 2019/0136280 | PROCESS FOR THE PRODUCTION OF ULTRAPURE GALACTO-OLIGOSACCHARIDES | Pharmaceuticals | Ritter Pharmaceuticals, Inc. · patent 11,028,422 granted from it |
| Sep 6, 2018 | 2018/0250324 | PREBIOTIC FORMULATIONS AND METHODS OF USE | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Aug 3, 2017 | 2017/0216328 | METHODS AND COMPOSITIONS FOR MICROBIOME ALTERATION | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Dec 22, 2016 | 2016/0367579 | PREBIOTIC FORMULATIONS AND METHODS OF USE | Pharmaceuticals | Ritter Pharmaceuticals, Inc. · patent 9,808,481 granted from it |
| Apr 21, 2016 | 2016/0108447 | PROCESS FOR THE PRODUCTION OF ULTRAPURE GALACTO-OLIGOSACCHARIDES | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
| Jan 14, 2016 | 2016/0008384 | PREBIOTIC FORMULATIONS AND METHODS OF USE | Pharmaceuticals | Ritter Pharmaceuticals, Inc. · patent 9,592,248 granted from it |
| Dec 31, 2015 | 2015/0374739 | PREBIOTIC FORMULATIONS AND METHODS OF USE | Pharmaceuticals | Ritter Pharmaceuticals, Inc. · patent 9,775,860 granted from it |
| Dec 31, 2015 | 2015/0374728 | PREBIOTIC FORMULATIONS AND METHODS OF USE | Pharmaceuticals | Ritter Pharmaceuticals, Inc. · patent 9,579,340 granted from it |
| May 14, 2015 | 2015/0133398 | Prebiotic Formulations and Methods of Use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. · patent 9,370,532 granted from it |
| Apr 30, 2015 | 2015/0118297 | Prebiotic Formulations and Methods of Use | Pharmaceuticals | Ritter Pharmaceuticals, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.